The study authors also said that drugs targeting endothelial activation should be used to control inflammation and coagulopathy associated with COVID-19
Elevated levels of plasmin in body may be reason behind severe COVID-19 in patients with comorbidities
Plasmin is an enzyme that breaks down fibrin (a protein that forms mesh in a blood clot) and dissolves blood clots in the body.
Abnormal blood clotting in COVID-19 patients: Researchers at Yale Cancer Centre explain why it occurs and how it could be detected early
The scientists stated that the risk of blood clotting can be predicted early in COVID-19 patients by measuring the levels of P-selectin, thrombomodulin, sCD40L and VWF in their blood.